Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175,888 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative efficacy of everolimus plus exemestane versus fulvestrant for hormone-receptor-positive advanced breast cancer following progression/recurrence after endocrine therapy: a network meta-analysis.
Bachelot T, McCool R, Duffy S, Glanville J, Varley D, Fleetwood K, Zhang J, Jerusalem G. Bachelot T, et al. Among authors: zhang j. Breast Cancer Res Treat. 2014 Jan;143(1):125-33. doi: 10.1007/s10549-013-2778-5. Epub 2013 Nov 24. Breast Cancer Res Treat. 2014. PMID: 24272078 Free PMC article.
Health-related quality of life and disease symptoms in postmenopausal women with HR(+), HER2(-) advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy.
Campone M, Beck JT, Gnant M, Neven P, Pritchard KI, Bachelot T, Provencher L, Rugo HS, Piccart M, Hortobagyi GN, Nunzi M, Heng DY, Baselga J, Komorowski A, Noguchi S, Horiguchi J, Bennett L, Ziemiecki R, Zhang J, Cahana A, Taran T, Sahmoud T, Burris HA 3rd. Campone M, et al. Among authors: zhang j. Curr Med Res Opin. 2013 Nov;29(11):1463-73. doi: 10.1185/03007995.2013.836078. Epub 2013 Sep 4. Curr Med Res Opin. 2013. PMID: 23962028 Clinical Trial.
Lifetime Costs for Treated Follicular Lymphoma Patients in the US.
Eichten C, Ma Q, Delea TE, Hagiwara M, Ramos R, Iorga ŞR, Zhang J, Maziarz RT. Eichten C, et al. Among authors: zhang j. Pharmacoeconomics. 2021 Oct;39(10):1163-1183. doi: 10.1007/s40273-021-01052-3. Epub 2021 Jul 17. Pharmacoeconomics. 2021. PMID: 34273085
Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework.
Lakdawalla DN, Shafrin J, Hou N, Peneva D, Vine S, Park J, Zhang J, Brookmeyer R, Figlin RA. Lakdawalla DN, et al. Among authors: zhang j. Value Health. 2017 Jul-Aug;20(7):866-875. doi: 10.1016/j.jval.2017.04.003. Epub 2017 May 16. Value Health. 2017. PMID: 28712615 Free article.
175,888 results
You have reached the last available page of results. Please see the User Guide for more information.